UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032000
Receipt number R000036525
Scientific Title A single center non randomized open-label comparative study using historical controls to verify the effectiveness of plasma exchange therapy for patients with anti-MDA 5 antibody positive rapidly progressive interstitial pneumonia
Date of disclosure of the study information 2018/04/01
Last modified on 2023/04/04 09:58:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single center non randomized open-label comparative study using historical controls to verify the effectiveness of plasma exchange therapy for patients with anti-MDA 5 antibody positive rapidly progressive interstitial pneumonia

Acronym

Efficacy of plasma exchange therapy for anti-MDA5 antibody positive interstitial pneumonia

Scientific Title

A single center non randomized open-label comparative study using historical controls to verify the effectiveness of plasma exchange therapy for patients with anti-MDA 5 antibody positive rapidly progressive interstitial pneumonia

Scientific Title:Acronym

Efficacy of plasma exchange therapy for anti-MDA5 antibody positive interstitial pneumonia

Region

Japan


Condition

Condition

Interstitial pneumonia

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Validate the usefulness of plasma exchange therapy for refractory anti-MDA5 antibody positive interstitial pneumonia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

One year survival rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Plasma exchange.
Plasma exchange therapy should be performed once with 2.0 to 3.0 L and three times as one course. Nafamostat mesilate is used as an anticoagulant and fresh frozen plasma is used as a replenisher. Until the introduction of remission, the number of enforcement courses will be decided appropriately between 1 and 6 courses depending on the condition. For this reason, the total number of plasma exchange therapies ranges from 3 to a maximum of 18, resulting in a fresh frozen plasma transfusion volume of 6.0 L to 54.0 L.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient who was newly developed or relapsed this time diagnosed as anti-MDA5 antibody positive interstitial pneumonia which is treatment-resistant to standard treatment acquired agreement over 20 years in writing.

Key exclusion criteria

When there is withdrawal of consent of research cooperation from research subjects.
When the whole research is canceled.
In cases where the researcher judges that the cancellation of research is appropriate for other reasons.
When adverse reactions with difficult plasma continuation therapy appear.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Naoto
Middle name
Last name Tamura

Organization

Juntendo university

Division name

Department of internal medicine and rheumatology

Zip code

1130033

Address

2-1-1, Hongo, Bunkyo-Ku, Tokyo, Japan

TEL

0338133111

Email

tnaoto@juntendo.ac.jp


Public contact

Name of contact person

1st name Yoshiyuki
Middle name
Last name Abe

Organization

Juntendo university

Division name

Department of Internal Medicine and Rheumatology

Zip code

1130033

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

0338133111

Homepage URL


Email

yo-abe@juntendo.ac.jp


Sponsor or person

Institute

Juntendo university

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University

Address

2-1-1, Hongo, Bunkyo-Ku

Tel

0338133111

Email

yo-abe@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂醫院


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 01 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000036525

Publication of results

Unpublished


Result

URL related to results and publications

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000036525

Number of participants that the trial has enrolled

0

Results

No entry.

Results date posted

2023 Year 04 Month 04 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

None

Participant flow

None

Adverse events

None

Outcome measures

None

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 03 Month 30 Day

Date of IRB

2018 Year 03 Month 23 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 30 Day

Last modified on

2023 Year 04 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036525


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name